".@EuniceWangMD, of @RoswellPark, discusses the long-term results of a phase 2 trial investigating crenolanib plus chemotherapy in adult patients with newly diagnosed FLT3-mutant AML. #leusm #oncology https://t.co/K8T1WM39II"

crenolanib besylate (ARO-002) - AROG

Jul 23, 2022